Michele Keough

Michele brings to Atalanta more than 20 years of product development experience in the biopharmaceutical industry. She specializes in advancing novel therapeutic product candidates through all stages of development to commercial launch. Most recently, Michele was senior vice president of R&D operations at Aura Biosciences, where she was responsible for advancing the company’s lead asset to FIH clinical trials. Prior to Aura, she was head of operations at Moderna Therapeutics. Michele also spent more than 15 years in positions of increasing responsibility with Genzyme, providing leadership for program and alliance management in multiple therapeutic areas, including cardiovascular, pulmonology and rare and orphan diseases. Michele holds an MBA from Duke University, an M.S. in immunology from Drexel University and a B.S. from the University of Delaware.

Michele spends her (limited!) free time with her husband and three teenagers. She also enjoys playing the piano and escapes to yoga class whenever possible.